Free Trial

Tyra Biosciences (TYRA) SEC Filings & 10K Form

Tyra Biosciences logo
$9.94 -0.08 (-0.78%)
As of 12:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Tyra Biosciences SEC Filings

DateFilerForm TypeView
03/31/2025
3:54 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13D/A
03/18/2025
5:44 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
5:02 PM
TCG Crossover GP I, LLC (Filed by)
Tyra Biosciences (Subject)
Form SCHEDULE 13G
02/07/2025
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:42 PM
Canaan XI L.P. (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
3:41 PM
Canaan 2020+ Co-Investment L.P. Series 7 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
4:09 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:00 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
4:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:42 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
8:30 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
12/05/2024
3:21 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:06 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:31 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/14/2024
4:52 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:47 PM
NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:34 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/13/2024
5:04 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/08/2024
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:24 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:18 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:22 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
4:15 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
6:00 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:01 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:15 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
7:47 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:49 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:11 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
4:13 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:04 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:12 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
4:51 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
8:59 PM
Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/15/2024
6:22 PM
Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/02/2024
4:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
M.A.G.A. is Finished – This Could be even Better (Ad)

You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).

When you see what could happen – I think you’ll be excited.
09/20/2024
5:24 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:49 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:42 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:56 PM
Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:59 PM
Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:27 PM
Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
4:12 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:15 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:49 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:53 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:50 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:55 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:18 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:10 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
2:08 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:26 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Simson Jake (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:46 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:48 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:08 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TYRA) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners